Nisoldipine--a new calcium channel blocker for hypertension.
Nisoldipine (Sular-Zeneca), a dihydropyridine calcium-channel blocker structurally similar to nifedipine, has been approved for marketing by the US Food and Drug Administration. It is available in an oral extended-release formulation for treatment of hypertension.